(Q34111475)

English

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

multiple myeloma

1 reference

based on heuristic

inferred from title

Herve Avet-Loiseau

object named as

H Avet-Loiseau

12

0 references

object named as

R Hajek

13

0 references

Giampaolo Merlini

object named as

G Merlini

6

0 references

Athanasios Dimopoulos

object named as

M Dimopoulos

10

0 references

International Myeloma Working Group

27

object named as

International Myeloma Working Group

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

object named as

R A Kyle

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

S. Vincent Rajkumar

3

object named as

S V Rajkumar

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

21

object named as

B Barlogie

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

object named as

B G M Durie

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

O Landgren

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J Blade

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

N Kröger

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

H Einsele

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

D H Vesole

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J San Miguel

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

W M Chen

14

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

K C Anderson

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

H Ludwig

16

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

P Sonneveld

17

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

S Pavlovsky

18

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

A Palumbo

19

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

P G Richardson

20

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

P Greipp

22

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R Vescio

23

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

I Turesson

24

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J Westin

25

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

M Boccadoro

26

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

22 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1121-1127

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

https://scigraph.springernature.com/pub.10.1038/leu.2010.60

0 references

Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Solitary plasmacytoma of bone and asymptomatic multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically relevant end points and new drug approvals for myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of monoclonal gammopathy of undetermined significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20410922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LEU.2010.60

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34111475&oldid=2076607331"